Cargando…
Predictive factors for effective selection of Interleukin-6 inhibitor and tumor necrosis factor inhibitor in the treatment of rheumatoid arthritis
Treatment of rheumatoid arthritis (RA) is aimed at long-term remission and inhibition of joint destruction by different biologic drugs. However, the choice of a particular biologic agent based on individual cases of RA remains unestablished. Interleukin-6 (IL-6) inhibitor and tumor necrosis factor (...
Autores principales: | Hayashi, Shinya, Matsubara, Tsukasa, Fukuda, Koji, Funahashi, Keiko, Hashimoto, Marowa, Maeda, Toshihisa, Kamenaga, Tomoyuki, Takashima, Yoshinori, Matsumoto, Tomoyuki, Niikura, Takahiro, Kuroda, Ryosuke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538428/ https://www.ncbi.nlm.nih.gov/pubmed/33024253 http://dx.doi.org/10.1038/s41598-020-73968-3 |
Ejemplares similares
-
A genome-wide association study identifying the SNPs predictive of rapid joint destruction in patients with rheumatoid arthritis
por: Hayashi, Shinya, et al.
Publicado: (2021) -
Comparison of the inhibitory effect of tocilizumab and etanercept on the progression of joint erosion in rheumatoid arthritis treatment
por: Hayashi, Shinya, et al.
Publicado: (2022) -
A genome-wide association study identifying single nucleotide polymorphisms in the PPFIBP2 gene was predictive for interstitial lung disease in rheumatoid arthritis patients
por: Hayashi, Shinya, et al.
Publicado: (2022) -
Susceptibility of cyclin-dependent kinase inhibitor 1-deficient mice to rheumatoid arthritis arising from interleukin-1β-induced inflammation
por: Takashima, Yoshinori, et al.
Publicado: (2021) -
Peri-prosthetic bone remodeling of hydroxyapatite-coated compaction short stem was not affected by stem alignment
por: Hayashi, Shinya, et al.
Publicado: (2022)